A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation

Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 10.1053/j.gastro.2013.02.042 Arroyo, 2016, Acute-on-chronic liver failure in cirrhosis, Nat Rev Dis Prim, 2, 16041, 10.1038/nrdp.2016.41 Arroyo, 2020, Acute-on-chronic liver failure, N Engl J Med, 382, 2137, 10.1056/NEJMra1914900 Trebicka, 2019, Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis, Front Immunol, 10, 476, 10.3389/fimmu.2019.00476 Katoonizadeh, 2010, Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study, Gut, 59, 1561, 10.1136/gut.2009.189639 Korf, 2019, Inhibition of glutamine synthetase in monocytes from patients with acute-on-chronic liver failure resuscitates their antibacterial and inflammatory capacity, Gut, 68, 1872, 10.1136/gutjnl-2018-316888 Moreau, 2020, Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF, J Hepatol, 72, 688, 10.1016/j.jhep.2019.11.009 Mahmud, 2019, Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis, Hepatology, 69, 2150, 10.1002/hep.30494 Shi, 2015, Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults, Hepatology, 62, 232, 10.1002/hep.27795 Li, 2016, Characteristics, Diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B, Sci Rep, 6, 25487, 10.1038/srep25487 2018, EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 Banares, 2013, Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial, Hepatology, 57, 1153, 10.1002/hep.26185 Gerth, 2017, Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure – a retrospective analysis, Crit Care Med, 45, 1616, 10.1097/CCM.0000000000002562 Sanyal, 2008, A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome, Gastroenterology, 134, 1360, 10.1053/j.gastro.2008.02.014 Chan, 2015, Criteria for liver transplantation in ACLF and outcome, Hepatol Int, 9, 355, 10.1007/s12072-014-9585-x Allen, 2016, Time trends in the health care burden and mortality of acute on chronic liver failure in the United States, Hepatology, 64, 2165, 10.1002/hep.28812 Le Blanc, 2008, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study, Lancet, 371, 1579, 10.1016/S0140-6736(08)60690-X Caplan, 2017, Mesenchymal stem cells: time to change the name!, Stem Cell Transl Med, 6, 1445, 10.1002/sctm.17-0051 Shi, 2012, Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients, Stem Cell Transl Med, 1, 725, 10.5966/sctm.2012-0034 Lin, 2017, Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial, Hepatology, 66, 209, 10.1002/hep.29189 Najimi, 2007, Adult-derived human liver mesenchymal-like cells as a potential progenitor reservoir of hepatocytes?, Cell Transpl, 16, 717, 10.3727/000000007783465154 Sokal, 2017, Biodistribution of liver-derived mesenchymal stem cells after peripheral injection in a hemophilia a patient, Transplantation, 101, 1845, 10.1097/TP.0000000000001773 Najar, 2018, Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features, Hepatobil Surg Nutr, 7, 331, 10.21037/hbsn.2018.05.01 Lombard, 2019, Human hepatocytes and differentiated adult-derived human liver stem/progenitor cells display in vitro immunosuppressive properties mediated, at least in part, through the nonclassical HLA Class I molecule HLA-G, J Immunol Res, 2019 El-Kehdy, 2017, Immunoprofiling of adult-derived human liver stem/progenitor cells: impact of hepatogenic differentiation and inflammation, Stem Cell Int, 2017 Najimi, 2017, Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation, Stem Cell Res Ther, 8, 131, 10.1186/s13287-017-0575-5 Smets, 2019, Transplantation, 103, 1903, 10.1097/TP.0000000000002605 Scheers, 2012, Adult-derived human liver progenitor cells in long-term culture maintain appropriate gatekeeper mechanisms against transformation, Cell Transpl, 21, 2241, 10.3727/096368912X639026 2016 2013 2008 Kujovich, 2015, Coagulopathy in liver disease: a balancing act, Hematol Am Soc Hematol Educ Program, 2015, 243, 10.1182/asheducation-2015.1.243 Perlee, 2018, Intravenous infusion of human adipose mesenchymal stem cells modifies the host response to lipopolysaccharide in humans: a randomized, single-blind, parallel group, placebo controlled trial, Stem Cells, 36, 1778, 10.1002/stem.2891 Moll, 2015, Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua, Stem Cell Dev, 24, 2269, 10.1089/scd.2015.0120 Coppin, 2020, Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders, Stem Cell Res Ther, 11, 51, 10.1186/s13287-020-1572-7 Stephenne, 2012, Bivalirudin in combination with heparin to control mesenchymal cell procoagulant activity, PloS One, 7, 10.1371/journal.pone.0042819 Moll, 2019, Intravascular mesenchymal stromal/stem cell therapy product diversification: time for new clinical guidelines, Trend Mol Med, 25, 149, 10.1016/j.molmed.2018.12.006 Moll, 2014, Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?, Stem Cells, 32, 2430, 10.1002/stem.1729 Muciño-Bermejo, 2013, Coagulation abnormalities in the cirrhotic patient, Ann Hepatol, 12, 713, 10.1016/S1665-2681(19)31312-2 Tripodi, 2005, Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests, Hepatology, 41, 553, 10.1002/hep.20569 Fisher, 2018, Balanced haemostasis with both hypo- and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure, J Crit Care, 43, 54, 10.1016/j.jcrc.2017.07.053